Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial
Importance: Approximately one-third of patients with peripheral artery disease experience intermittent claudication, with consequent loss of quality of life. Objective: To determine the efficacy of ramipril for improving walking ability, patient-perceived walking performance, and quality of life in...
| Main Authors: | Ahimastos, A., Walker, P., Askew, C., Leicht, A., Pappas, E., Blombery, P., Reid, Christopher, Golledge, J., Kingwell, B. |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/48143 |
Similar Items
Early result: randomized controlled trial of treatment for intermittent claudication
by: Khan, Mazari Fayyaz Ali, et al.
Published: (2008)
by: Khan, Mazari Fayyaz Ali, et al.
Published: (2008)
Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men
by: Yeap, B., et al.
Published: (2013)
by: Yeap, B., et al.
Published: (2013)
Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
Randomized clinical trial of percutaneous transluminalangioplasty, supervised exercise and combined treatment forintermittent claudication due to femoropopliteal arterial disease
by: Mazari, F. A. K., et al.
Published: (2012)
by: Mazari, F. A. K., et al.
Published: (2012)
Treatment of intermittent claudication due to infra inguinal disease: results of a randomised control trial
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
A RCT of non-surgical treatment for intermittent claudication in femoro-popliteal disease: 12-month results
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
Popliteal artery entrapment syndrome: a rare cause of claudication in young athlete
by: Suraya A,, et al.
Published: (2011)
by: Suraya A,, et al.
Published: (2011)
Presentation and outcomes of indigenous Australians with peripheral artery disease
by: Singh, T., et al.
Published: (2018)
by: Singh, T., et al.
Published: (2018)
Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial
by: Burton, N., et al.
Published: (2016)
by: Burton, N., et al.
Published: (2016)
Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])
by: Cowan, B., et al.
Published: (2009)
by: Cowan, B., et al.
Published: (2009)
An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
by: Morris, D., et al.
Published: (2015)
by: Morris, D., et al.
Published: (2015)
Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study
by: Si, Si, et al.
Published: (2018)
by: Si, Si, et al.
Published: (2018)
Update on the management of peripheral arterial disease (PAD)
by: Liew, Ngoh Chin, et al.
Published: (2011)
by: Liew, Ngoh Chin, et al.
Published: (2011)
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics
by: Cowan, B., et al.
Published: (2009)
by: Cowan, B., et al.
Published: (2009)
Erratum to: 'TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial'
by: Morris, D.R., et al.
Published: (2016)
by: Morris, D.R., et al.
Published: (2016)
Do Quality of Life (QOL) index scores truly reflect the degree of clinical improvement following intervention in patients with intermittent claudication due to femoro-popliteal disease? results of an observational study
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)
Cost utility analysis of a randomised control trial of percutaneoustransluminal angioplasty (PTA), supervised exercise programme (SEP)
and combined treatment (PTA+SEP) for patients with intermittent
claudication (IC) due to femoropopliteal disease
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010)
Some results associated with random walks
by: Deligiannidis, Georgios
Published: (2010)
by: Deligiannidis, Georgios
Published: (2010)
Dynamical continuous time random walk
by: Liu, Jian, et al.
Published: (2015)
by: Liu, Jian, et al.
Published: (2015)
Random walk and the stock market of Malaysia
by: Othman Yong,
Published: (1985)
by: Othman Yong,
Published: (1985)
Fluid-structure interaction modelling of blood flow in peripheral arterial disease
by: Muhammad Firdaus, Mohd Fauzi, et al.
Published: (2024)
by: Muhammad Firdaus, Mohd Fauzi, et al.
Published: (2024)
Can the Random Walk be beat on the Forex Market?
by: Richard de Vesvrotte, Hubert
Published: (2015)
by: Richard de Vesvrotte, Hubert
Published: (2015)
The Random Walk Hypothesis for Asean Stock Markets
by: Pan, Qi Qi
Published: (2014)
by: Pan, Qi Qi
Published: (2014)
Stock market : random walk or mean reverting?
by: Sim, Gin Khai
Published: (2011)
by: Sim, Gin Khai
Published: (2011)
Brief review on recent advancement of computational analysis on hemodynamics in peripheral artery disease
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2023)
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2023)
Prediction of atherosclerosis in peripheral arterial disease using computational fluid dynamics modelling
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2024)
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2024)
Nurse-led risk assessment/management clinics reduce predicted cardiac morbidity and mortality in claudicants
by: Hatfield, Josephine, et al.
Published: (2008)
by: Hatfield, Josephine, et al.
Published: (2008)
Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2021)
by: Ho, C.L.B., et al.
Published: (2021)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Dual Energy CT Angiography of Peripheral Arterial Disease: Feasibility of Using Lower Contrast Medium Volume
by: Almutairi, A., et al.
Published: (2015)
by: Almutairi, A., et al.
Published: (2015)
The random walk as a forecasting benchmark: drift or no drift?
by: Moosa, I., et al.
Published: (2016)
by: Moosa, I., et al.
Published: (2016)
Current account: mean-reverting or random
walk behavior?
by: Lau, Evan, et al.
Published: (2006)
by: Lau, Evan, et al.
Published: (2006)
Generic Quality of Life analysis in claudicants: can the Short Form 8 replace the Short Form 36?
by: Gulati, Sumit M., et al.
Published: (2007)
by: Gulati, Sumit M., et al.
Published: (2007)
An Entropy-Based Directed Random Walk for Cancer Classification Using Gene Expression Data Based on
Bi-Random Walk on Two Separated Networks
by: Xin Hui Tay, Xin Hui Tay, et al.
Published: (2023)
by: Xin Hui Tay, Xin Hui Tay, et al.
Published: (2023)
Scanning protocol optimisation for dual-energy computed tomography angiography in peripheral artery stenting
by: Almutairi, Abdulrahman Marzouq
Published: (2016)
by: Almutairi, Abdulrahman Marzouq
Published: (2016)
Comparison of diabetic and non-diabetic patients undergoing endovascular revascularization for peripheral arterial disease
by: Michael, S. Lee, et al.
Published: (2015)
by: Michael, S. Lee, et al.
Published: (2015)
Numerical approach for the evaluation of hemodynamic behaviour in peripheral arterial disease : A systematic review
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2023)
by: Ukasyah Zulfaqar, Shahrulakmar, et al.
Published: (2023)
Evaluation of clinical outcome post lower limb angioplasty in peripheral arterial disease patient
by: Chin, Leong Yung
Published: (2017)
by: Chin, Leong Yung
Published: (2017)
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry
by: Abtan, J., et al.
Published: (2017)
by: Abtan, J., et al.
Published: (2017)
Similar Items
-
Early result: randomized controlled trial of treatment for intermittent claudication
by: Khan, Mazari Fayyaz Ali, et al.
Published: (2008) -
Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men
by: Yeap, B., et al.
Published: (2013) -
Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2010) -
Randomized clinical trial of percutaneous transluminalangioplasty, supervised exercise and combined treatment forintermittent claudication due to femoropopliteal arterial disease
by: Mazari, F. A. K., et al.
Published: (2012) -
Treatment of intermittent claudication due to infra inguinal disease: results of a randomised control trial
by: Mazari, Fayyaz Ali Khan, et al.
Published: (2009)